Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports

Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports Reuters

Early report Major update Updated Mar 25, 2026, 1:14 AM UTC

Track this event Edit in app More event pages

What changed

Reuters: Merck nears $6 billion acquisition of Terns Pharma to boost cancer portfolio, FT reports.

First seen Mar 25, 2026, 1:14 AM UTC Latest source Mar 25, 2026, 1:14 AM UTC

Update 1 4h ago

Reuters •published Mar 25, 2026, 1:14 AM UTC •fetched Mar 25, 2026, 4:10 AM UTC